Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366911 · ClinicalTrials.gov registry record
Stem Cells Predicting Orthopedic Outcomes
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 203
- Enrollment target
NCT01366911 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 203 participants.
The verdict
NCT01366911 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
Study Summary
This is a pilot study to provide preliminary data of the association between bone mineral denity adjacent to acetabular implants, as measured by quanitative computed tomography (QCT), at least 2 years post Total Hip Arthoplasty (THA) surgery with Mesechymal stem cell assays, obtained at time of surgery, and to begin to evaluate if stem cells can predict orthopaedic surgical outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2011-04-22 |
| Est. Completion | 2014-01-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366911
The ClinicalTrials.gov registry entry for NCT01366911 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01366911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366911 about?
NCT01366911 is a clinical study titled "Stem Cells Predicting Orthopedic Outcomes". This is a pilot study to provide preliminary data of the association between bone mineral denity adjacent to acetabular implants, as measured by quanitative computed tomography (QCT), at least 2 years post Total Hip Arthoplasty (THA) surgery with Mesechymal stem cell assays, obtained at time of surg...
What is the current status of trial NCT01366911?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2011-04-22. Estimated completion is 2014-01-10.
Who is sponsoring clinical trial NCT01366911?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.